Last Friday, at a bit after 3pm, former Liberal leader and prime minister Tony Abbott was elected unopposed as the party’s ...

Grail's multi-cancer blood test can find cancer — but there's still one big problem with how it works.

Earlier this week, the American Cancer Society updated its colorectal cancer screening guidelines, reaffirming Abbott’s ...

Abbott Laboratories has trailed the Dow Jones Industrial Average over the past year, but analysts remain highly optimistic ...

It's quick to spot a tick, but harder to know if that tick carries Lyme disease. Emergency room visits for tick bites provide important data for the Centers for Disease Control and Prevention, but ...

The Reds had a chance to win four straight games on Wednesday night against the Mets. The offense had been heating up, and a rotation of Nick Lodolo, Chase Burns, and Andrew Abbott in Queens set ...

Abbott (NYSE:ABT) announced today that it received CE mark approval for its dual glucose-ketone sensing technology for people ...

First-of-its-kind biowearables combine continuous glucose and ketone monitoring in a single sensor to support both daily diabetes management and help detect rising ketone levels that can lead ...

American Cancer Society guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening: Abbott Park, Illinois Thursday, May 28, 2026, 15:00 Hrs [IST] Abbott anno ...

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Neogen (NASDAQ:NEOG) and its peers. The medical devices industry ...

Abbott’s first dual-analyte sensor comes as competitors are working to develop their own versions of the technology.

Guardant Health stock spiked Wednesday after the American Cancer Society recommended its blood test as a screening tool for colon cancer.